Hepatitis B vaccine and hepatitis B markers: Cost effectiveness of screening prehospital personnel

Daniel G. Hankins, Karess D. Ebert, Constance M. Siebold, Timothy K. Fuller, Ralph J. Frascone, Brian C. Campion

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


The purpose of this study was to evaluate the cost effectiveness of screening emergency medical technicians (EMTs) and paramedical personnel prior to administering hepatitis B vaccine. Hepatitis B screening and Heptavax® vaccine were offered to 259 basic EMTs and paramedics. Of the 259 individuals, 62 refused screening, and six who had already recelved hepatitis B vaccine were excluded from the study. The screening was not continued after the results of the first 174 tests returned negative. All 191 participants were vaccinated. No hepatitis B surface antigen carriers and only three individuals positive for hepatitis B surface antibody were found among those screened. This study corroborates the Centers for Disease Control guidellnes of cost effectiveness in screening prehospital health care workers.

Original languageEnglish (US)
Pages (from-to)205-206
Number of pages2
JournalAmerican Journal of Emergency Medicine
Issue number3
StatePublished - May 1987

Bibliographical note

Funding Information:
Supported in part by St. Paul-Ramsey Foundation.


  • Hepatitis antibody
  • hepatitis B vaccine
  • hepatitis surface antigen


Dive into the research topics of 'Hepatitis B vaccine and hepatitis B markers: Cost effectiveness of screening prehospital personnel'. Together they form a unique fingerprint.

Cite this